サンプル依頼リスト カート
  • English
  • Korean
表紙：麻薬の世界市場レポート 2024年
市場調査レポート
商品コード
1415610

麻薬の世界市場レポート 2024年

Narcotic Drugs Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
麻薬の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

麻薬市場規模は近年力強く成長しています。2023年の135億6,000万米ドルから2024年には142億6,000万米ドルに、CAGR5.1％で拡大します。この期間の成長は、医療ニーズの増加、公衆衛生への関心の高まり、ヘルスケアへのアクセスの増加、慢性疼痛の有病率の上昇、疼痛管理を改善するための政府の取り組みなどに起因しています。

麻薬の市場規模は、今後数年間で安定した成長が見込まれます。2028年には複合年間成長率（CAGR）4.3%で168億8,000万米ドルに成長します。予測期間の成長は、ジェネリック麻薬の需要拡大、製薬業界の成長、低侵襲手術の需要拡大、緩和ケアにおける麻薬の使用増加などに起因しています。予測期間における主な動向としては、医薬品の技術革新、遠隔医療と遠隔モニタリング、非オピオイド代替薬の開発、創薬・開発における人工知能（AI）の活用などが挙げられます。

慢性疾患の有病率の増加が予想されることが、今後の麻薬市場成長の原動力になると予想されます。慢性疾患とは、3カ月以上続く長期的な病気で、時間の経過とともに悪化することが多いです。麻薬は、がん、慢性疼痛症候群、末期疾患、重度の関節炎などの症状を緩和することで、慢性疾患の疼痛管理に重要な役割を果たしています。例えば、2023年1月現在、米国の国立医学図書館（National Library of Medicine）のデータによると、米国では50歳以上で少なくとも1つの慢性疾患を持つ人の数が99.5％増加すると予測されています。この増加により、2020年には7,152万2,000人であったのが、2050年には1億4,266万人となります。したがって、慢性疾患の罹患率の増加は、麻薬市場の拡大に拍車をかける重要な要因です。

処方薬としてのオピオイドの使用拡大が、当面の麻薬市場の成長を牽引すると予想されます。オピオイドは、合法的に処方される薬物と違法薬物の両方を含む物質のカテゴリーであり、多幸感、リラックス、鎮静の感覚を誘発することで知られています。処方薬におけるオピオイドの使用量の増加が、麻薬の需要に寄与しています。オピオイドが麻薬に配合されているのは、その強力な鎮痛作用と鎮静作用が主な理由であり、特に代替の疼痛管理方法が不十分であることが判明した場合に有効です。例えば、2023年8月現在、スイスに本部を置く保健専門機関である世界保健機関（WHO）は、2021年に15歳から64歳の人口の5.8％を占める約2億9600万人が、少なくとも一度は薬物実験を行ったと報告しています。この層の中で、特にオピオイドを使用しているのは世界で約6000万人です。したがって、処方薬としてのオピオイド使用の増加が、麻薬市場成長の原動力となっています。

アジア太平洋は、2023年の麻薬市場において最大の地域でした。本麻薬レポートの対象地域は、アジア太平洋、西欧、中東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界の麻薬市場、薬物別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
  • アヘン
  • ヘロイン
  • コデイン
  • オキシコドン
  • その他の薬物
  • 世界の麻薬市場、由来別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
  • 自然
  • 半合成
  • 合成
  • 世界の麻薬市場、適応症別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 疼痛管理
  • 咳
  • 下痢
  • 赤痢
  • 喘息
  • その他の適応症
  • 世界の麻薬市場、流通チャネル別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
  • 病院薬局
  • オンライン薬局
  • 小売薬局
  • 世界の麻薬市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
  • 病院
  • 在宅ケア
  • 専門クリニック
  • その他のエンドユーザー

第7章 地域および国の分析

  • 世界の麻薬市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
  • 世界の麻薬市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 麻薬市場の競合情勢
  • 麻薬市場の企業プロファイル
    • Pfizer Inc.
    • Johnson and Johnson Limited
    • AbbVie Inc.
    • Novartis AG
    • AstraZeneca PLC

第31章 その他の主要および革新的な企業

  • Sanofi S.A.
  • Takeda Pharmaceutical Company Limited
  • Boehringer Ingelheim International GmbH
  • Viatris Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Daiichi Sankyo Company Limited
  • Sun Pharmaceutical Industries Ltd.
  • Purdue Pharma LP
  • Hikma Pharmaceuticals Plc
  • Endo Pharmaceuticals Inc.
  • Amneal Pharmaceuticals LLC
  • Lupin Ltd.
  • Mallinckrodt Pharmaceuticals
  • Alvogen Inc.
  • Indivior Inc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r12209

“Narcotic Drugs Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on narcotic drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for narcotic drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The narcotic drugs market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Drug: Opium; Heroin; Codeine; Oxycodone; Other Drugs
  • 2) By Source: Natural; Semi-Synthetic; Synthetic
  • 3) By Indication: Pain Management; Cough; Diarrhea; Dysentery; Asthma; Other Indications
  • 4) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
  • 5) By End User: Hospitals; Homecare; Specialty Clinics; Other End Users
  • Companies Mentioned: Pfizer Inc.; Johnson and Johnson Limited; AbbVie Inc.; Novartis AG; AstraZeneca PLC
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

A narcotic drug is a class of substances that affect the central nervous system, inducing effects like drowsiness, pain relief, euphoria, and sometimes hallucinations. These drugs are commonly derived from the opium poppy plant but can also be synthesized.

The key types of narcotic drugs include opium, heroin, codeine, oxycodone, and others. Opium is a bitter, brownish, addictive substance derived from the dried latex of immature seed capsules of the opium poppy. These narcotics come from various sources, which can be natural, semi-synthetic, or synthetic, and are used for a range of purposes, including pain management, cough suppression, diarrhea treatment, asthma relief, and more. They are distributed through a variety of channels, including hospital pharmacies, online pharmacies, and retail pharmacies, and are utilized by diverse end-users, such as hospitals, homecare services, specialty clinics, and others.

The narcotic drugs market research report is one of a series of new reports from The Business Research Company that provides narcotic drugs market statistics, including narcotic drugs industry global market size, regional shares, competitors with a narcotic drugs market share, detailed narcotic drugs market segments, market trends and opportunities and any further data you may need to thrive in the narcotic drugs industry. This narcotic drug market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The narcotic drugs market size has grown strongly in recent years. It will grow from $13.56 billion in 2023 to $14.26 billion in 2024 at a compound annual growth rate (CAGR) of 5.1%. The growth in the historic period can be attributed to increasing medical need, growing public health concerns, increasing access to healthcare, rising prevalence of chronic pain, government initiatives to improve pain management.

The narcotic drugs market size is expected to see steady growth in the next few years. It will grow to $16.88 billion in 2028 at a compound annual growth rate (CAGR) of 4.3%. The growth in the forecast period can be attributed to growing demand for generic narcotic drugs, growing pharmaceutical industry, growing demand for minimally invasive surgeries, increased use of narcotic drugs in palliative care. Major trends in the forecast period include pharmaceutical innovation, telemedicine and remote monitoring, development of non-opioid alternatives, use of artificial intelligence (ai) in drug discovery and development.

The anticipated increase in the prevalence of chronic diseases is expected to be a driving force behind the growth of the narcotic drug market in the future. Chronic diseases are long-term illnesses that persist for three months or longer and often worsen over time. Narcotic drugs play a critical role in managing chronic diseases by providing relief for conditions such as cancer, chronic pain syndromes, terminal illnesses, and severe arthritis. For example, as of January 2023, data from the National Library of Medicine, a US-based agency, indicates that the number of individuals in the United States aged 50 and older who have at least one chronic condition is projected to increase by 99.5%. This increase would see the number rise from 71.522 million in 2020 to 142.66 million by 2050. Therefore, the growing incidence of chronic diseases is a significant factor fueling the expansion of the narcotic drug market.

The expanding use of opioids as prescribed medications is anticipated to drive the growth of the narcotic drugs market in the foreseeable future. Opioids, a category of substances encompassing both legally prescribed drugs and illicit substances, are known for inducing sensations of euphoria, relaxation, and sedation. The rising utilization of opioids in prescription medications contributes to the demand for narcotic drugs. Opioids are integrated into narcotic drugs primarily due to their potent pain-relieving and sedative attributes, particularly when alternative pain management methods prove inadequate. For example, as of August 2023, the World Health Organization (WHO), a specialized health agency based in Switzerland, reported that in 2021, approximately 296 million individuals, accounting for 5.8% of the population aged 15-64 years, experimented with drugs at least once. Within this demographic, around 60 million people worldwide specifically used opioids. Hence, the increasing use of opioids as prescription medicine is a driving force behind the growth of the narcotic drugs market.

The growing regulatory challenges present a significant obstacle that may impede the market's expansion throughout the forecast period. Government authorities face challenges in law enforcement and regulation due to the escalating volumes of narcotic drug transportation, including substances like cannabis and new psychoactive substances (NPS). As an example, in June 2023, Forbes Media LLC, a U.S.-based media company, reported that the surge in truck drivers testing positive for marijuana since its legalization has led to the dismissal of over 100,000 drivers. Consequently, the increasing regulatory challenges are acting as a deterrent to the future growth of the narcotic drugs market.

Prominent companies within the narcotic drug market are placing a growing emphasis on product development and innovation to offer dependable products to their customers and bolster their positions in the market. As an example, in May 2023, Indivior PLC, a pharmaceutical company headquartered in the United States, introduced OPVEE (nalmefene) nasal spray. This product serves as an opioid overdose rescue medication designed for use with natural and synthetic opioids, including substances like fentanyl. It is recommended for immediate use in the treatment of known or suspected opioid overdoses in adults and pediatric patients aged 12 and older, particularly in cases involving respiratory and central nervous system depression. This development underscores the company's commitment to addressing critical medical needs and enhancing the safety of individuals at risk of opioid overdose.

In March 2023, Indivior PLC, a pharmaceutical company based in the United States, completed its acquisition of Opiant Pharmaceuticals Inc. for a total of $145 million. This strategic acquisition is intended to bolster Indivior PLC's portfolio in the field of addiction treatment and science. It is noteworthy that this acquisition includes OPNT003, an investigational opioid overdose treatment, which is seen as a crucial addition to address the ongoing opioid overdose crisis in the United States, particularly involving potent synthetic opioids like fentanyl. Opiant Pharmaceuticals Inc., a pharmaceutical company headquartered in the United States, specializes in the manufacturing of narcotic drugs. This acquisition reflects Indivior PLC's commitment to expanding its offerings in the fight against opioid overdoses and substance use disorders.

Major players in the narcotic drugs market are Pfizer Inc., Johnson and Johnson Limited, AbbVie Inc., Novartis AG, AstraZeneca PLC, Sanofi S.A., Takeda Pharmaceutical Company Limited, Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Sun Pharmaceutical Industries Ltd., Purdue Pharma LP, Hikma Pharmaceuticals PLC, Endo Pharmaceuticals Inc., Amneal Pharmaceuticals LLC, Lupin Ltd., Mallinckrodt Pharmaceuticals, Alvogen Inc., Indivior Inc., Impax Laboratories Inc., Collegium Pharmaceutical Inc., Lannett Co Inc., Par Pharmaceutical Inc., West-Ward Pharmaceuticals Corp.

Asia-Pacific was the largest region in the narcotic drugs market in 2023. The regions covered in the narcotic drug report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the narcotic drug market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, and Spain.

The narcotic drug market consists of sales of ketobemidone, pethidine, tolidine, and trimeperidine. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Narcotic Drugs Market Characteristics

3. Narcotic Drugs Market Trends And Strategies

4. Narcotic Drugs Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Narcotic Drugs Market Size and Growth

  • 5.1. Global Narcotic Drugs Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Narcotic Drugs Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Narcotic Drugs Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Narcotic Drugs Market Segmentation

  • 6.1. Global Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Opium
  • Heroin
  • Codeine
  • Oxycodone
  • Other Drugs
  • 6.2. Global Narcotic Drugs Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Natural
  • Semi-Synthetic
  • Synthetic
  • 6.3. Global Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pain Management
  • Cough
  • Diarrhea
  • Dysentery
  • Asthma
  • Other Indications
  • 6.4. Global Narcotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy
  • 6.5. Global Narcotic Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Homecare
  • Specialty Clinics
  • Other End Users

7. Narcotic Drugs Market Regional And Country Analysis

  • 7.1. Global Narcotic Drugs Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Narcotic Drugs Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Narcotic Drugs Market

  • 8.1. Asia-Pacific Narcotic Drugs Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Narcotic Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Narcotic Drugs Market

  • 9.1. China Narcotic Drugs Market Overview
  • 9.2. China Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Narcotic Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Narcotic Drugs Market

  • 10.1. India Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Narcotic Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Narcotic Drugs Market

  • 11.1. Japan Narcotic Drugs Market Overview
  • 11.2. Japan Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Narcotic Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Narcotic Drugs Market

  • 12.1. Australia Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Narcotic Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Narcotic Drugs Market

  • 13.1. Indonesia Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Narcotic Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Narcotic Drugs Market

  • 14.1. South Korea Narcotic Drugs Market Overview
  • 14.2. South Korea Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Narcotic Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Narcotic Drugs Market

  • 15.1. Western Europe Narcotic Drugs Market Overview
  • 15.2. Western Europe Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Narcotic Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Narcotic Drugs Market

  • 16.1. UK Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Narcotic Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Narcotic Drugs Market

  • 17.1. Germany Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Narcotic Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Narcotic Drugs Market

  • 18.1. France Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Narcotic Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Narcotic Drugs Market

  • 19.1. Italy Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Narcotic Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Narcotic Drugs Market

  • 20.1. Spain Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Narcotic Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Narcotic Drugs Market

  • 21.1. Eastern Europe Narcotic Drugs Market Overview
  • 21.2. Eastern Europe Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Narcotic Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Narcotic Drugs Market

  • 22.1. Russia Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Narcotic Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Narcotic Drugs Market

  • 23.1. North America Narcotic Drugs Market Overview
  • 23.2. North America Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Narcotic Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Narcotic Drugs Market

  • 24.1. USA Narcotic Drugs Market Overview
  • 24.2. USA Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Narcotic Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Narcotic Drugs Market

  • 25.1. Canada Narcotic Drugs Market Overview
  • 25.2. Canada Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Narcotic Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Narcotic Drugs Market

  • 26.1. South America Narcotic Drugs Market Overview
  • 26.2. South America Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Narcotic Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Narcotic Drugs Market

  • 27.1. Brazil Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Narcotic Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Narcotic Drugs Market

  • 28.1. Middle East Narcotic Drugs Market Overview
  • 28.2. Middle East Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Narcotic Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Narcotic Drugs Market

  • 29.1. Africa Narcotic Drugs Market Overview
  • 29.2. Africa Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Narcotic Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Narcotic Drugs Market Competitive Landscape And Company Profiles

  • 30.1. Narcotic Drugs Market Competitive Landscape
  • 30.2. Narcotic Drugs Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Johnson and Johnson Limited
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. AbbVie Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Novartis AG
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. AstraZeneca PLC
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Narcotic Drugs Market Other Major And Innovative Companies

  • 31.1. Sanofi S.A.
  • 31.2. Takeda Pharmaceutical Company Limited
  • 31.3. Boehringer Ingelheim International GmbH
  • 31.4. Viatris Inc.
  • 31.5. Teva Pharmaceutical Industries Ltd.
  • 31.6. Daiichi Sankyo Company Limited
  • 31.7. Sun Pharmaceutical Industries Ltd.
  • 31.8. Purdue Pharma LP
  • 31.9. Hikma Pharmaceuticals Plc
  • 31.10. Endo Pharmaceuticals Inc.
  • 31.11. Amneal Pharmaceuticals LLC
  • 31.12. Lupin Ltd.
  • 31.13. Mallinckrodt Pharmaceuticals
  • 31.14. Alvogen Inc.
  • 31.15. Indivior Inc.

32. Global Narcotic Drugs Market Competitive Benchmarking

33. Global Narcotic Drugs Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Narcotic Drugs Market

35. Narcotic Drugs Market Future Outlook and Potential Analysis

  • 35.1 Narcotic Drugs Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Narcotic Drugs Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Narcotic Drugs Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer